Whey protein boom: Weight-loss drugs drive demand for New Zealand dairy
Prices for whey powder in its key market, the United States, were soaring this year. Rabobank said in…
Doctors considering weight-loss drugs for detained man to be kept in physical restraints
The hearing has been delayed for almost a year because of trouble securing court time and the availability…
From 90 Kg To 72 Kg: Ravi Kishan Shares How He Lost 18 Kg With OMAD
Actor-politician Ravi Kishan has proved that weight loss does not have to necessarily come from restrictive diets or…
New GLP-1 Clinical Study Finds Calocurb Reduces Body Weight and Fat » World Business Outlook
Calocurb, the New Zealand-based company bringing the world the first 100% natural GLP-1 activator, recently announced the publication…
Sport chiefs monitor slimming drugs as bodybuilding use surges
Eric Helms, the co-director of the AUT Sport Research Institute New Zealand (Sprinz) and a natural bodybuilder, said…
‘Take off your kneepads’: Shane Jones’ dig at Luxon over Modi visit, reveals weight-loss drug use
He delivered a crass, veiled dig at Luxon, who often has an affectionate nature when meeting with foreign…
She lied about her weight and was prescribed weight-loss medication
Rose was able to use AI to craft images that made her look different and gain access to…
Nutritionists sound alarm as weight-loss jabs fuel ‘skinny culture’ comeback
“For a little while there, it felt like we had a bit of reprieve, but it definitely feels…
Steroids, peptides and the growth of an unregulated ‘grey market’ of drugs in NZ
The recent wellness peptide craze is leading people to inject largely unregulated peptides into their bodies for a…
13 surprising ways GLP-1 weight-loss drugs may benefit the body, according to science
A condition-by-condition guide to GLP-1 drugs breaks down what’s proven, what’s promising and what’s still untested. Humans have…
Coast FM star’s image used for fake weight loss ads
‘Makes me angry’: Coast FM star’s image used for fake weight loss ads ZB Choose a region Shows…
Is the ‘Ozempic era’ an opportunity for no-and-low?
With growing research to suggest GLP-1 drugs reduce the desire to drink alcohol, Eloise Feilden asks whether the…